CareLit · DOI-Nachweis · Klinische Pädiatrie
Haematopoietic chimerism and donor lymphocyte infusion after allogeneic SCT in children with non-malignant disease: is there an option to improve outcome?
DOI 10.1055/s-2004-828575
Bibliografische Angaben
Nachweis in CareLit
Autor:innenW Hoelle, H Kreyenberg, P Lang, J Greil, D Niethammer, JF Beck, T Klingebiel, P Bader
ZeitschriftKlinische Pädiatrie
Ausgabe05/2004
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Allo–SCT is a well-established treatment modality for children with several acquired and inherited disease affecting the haematopoietic stem cell or their derivatives. Treatment failures after allo–SCT are mostly caused by graft rejection (GR). Increasing mixed chimerism (in-MC) represents a stage at the very beginning of graft rejection, where immunological intervention might be an effective prophylactic approach.…
Zitieren
Zitierempfehlung
W Hoelle, H Kreyenberg, P Lang, J Greil, D Niethammer, JF Beck, T Klingebiel, P Bader (2004) Haematopoietic chimerism and donor lymphocyte infusion after allogeneic SCT in children with non-malignant disease: is there an option to improve outcome?. Klinische Pädiatrie (05). https://doi.org/10.1055/s-2004-828575
Mit CareLit weiterarbeiten